Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

2009 HBV Symposium

This symposium was titled “Drug-resistant and Vaccine-escape Hepatitis B Virus Mutants: Emergence and Surveillance”.  It was held June 4 and 5, 2009 at the CDC’s Roybal Campus in Atlanta. A unique array of international experts presented the latest findings and there was ample opportunity for an exchange of ideas and a discussion of strategies for surveillance of emerging mutants.

Thursday,  June 4, 2009
TIME
EVENT
12 noon
Light refreshments
Introduction
1:00 p.m.
Welcome
John Ward, CDC
1:15 p.m.
CDC’s viral hepatitis surveillance
Scott Holmberg, CDC
Session I : Contexts of HBV mutant emergence and clinical implications
(Moderators: John Ward, CDC, & Susan Stramer, American Red Cross, Gaithersburg, MD)
1:30 p.m.
Molecular genesis of drug-resistant and vaccine-escape HBV mutants
Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
2.00 p.m.
Q & A
2:10 p.m.
HBV S-gene mutants in chronic Hepatitis B patients given nucleos(t)ide-analog therapy
Chau-Ting Yeh, Chang Gung University, Taipeh, Taiwan
2:40 p.m.
Q & A
2.50 p.m.
Multidrug-resistant HBV mutants
Anna Lok, University of Michigan, Ann Arbor, MI
3.20 p.m.
Q & A
3.30 p.m.
Virology and clinical sequelae of HBV mutants in HIV/HBV-coinfected patients given HAART
Chloe Thio, Johns Hopkins University, Baltimore, MD
4:00 p.m.
Q & A
4:10 p.m.
Break
Session II : Settings for surveillance for HBV mutants
(Moderators: David Bell, CDC, & Anna Lok, University of Michigan, Ann Arbor, MI)
4:30 p.m.
Breakthrough HBV infection in vaccinated Taiwanese children
Mei-Hwei Chang, National Taiwan University, Taipei, Taiwan
5:00 p.m.
Q & A
5:10 p.m.
Breakthrough HBV infection in vaccinated American blood donors
Susan Stramer, American Red Cross, Gaithersburg, MD
5:40 p.m.
Q & A
5:50 p.m.
HBV/HIV-coinfected patients receiving HAART: the French HIV-HBV Cohort Study
Karine Lacombe, INSERM UMR-S707, Paris, France
6.20 p.m.
Q & A
6.30 p.m.
HBV/HIV-coinfected South African patients receiving first-line ART
Adrian Di Bisceglie, St Louis University, St Louis, MN
7.00 p.m.
Q & A
7.10 p.m.
Evening Reception
9.00 p.m.
Adjourn
      


Friday,  June 5, 2009
TIME
EVENT
7:30 a.m.
Breakfast
Session III: Laboratory approaches to surveillance (1)
(Moderators: Chong-Gee Teo, CDC, & David Durantel, INSERM U871, Lyon, France)
8:30 a.m.
CDC’s surveillance for drug-resistant HIV
Walid Heneine, CDC
9.00 a.m.
Q & A
9.10 a.m.
Deep sequencing and network analysis of HBV genomes
Yuri Khudyakov, CDC
9.40 a.m.
Q & A
9.50 a.m.
Databases for characterizing HBV mutants and their hosts
Carla Kuiken, Los Alamos National Laboratory, Los Alamos, NM
10.20 a.m.
Q & A
10.30 a.m.
Drug-resistant HBV variants: genotypic determinants and phenotypic alterations
Daniel Tenney, Bristol-Myers Squibb, Wallingford, CT
11.00 a.m.
Q & A
11.10 a.m.
Break
Session IV: Laboratory approaches to surveillance (2)
(Moderators: Kris Krawczynski, CDC, & Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia)
11.30 a.m.
Fitness and infectivity of drug-resistant and -cross-resistant HBV mutants
David Durantel, INSERM U871, Lyon, France
12.00 noon
Q & A
12.10 p.m.
Modulation of HBV secretion by mutations in the S gene
Shuping Tong, Brown University, Providence, RI
12.40 p.m.
Q & A
12.50 p.m.
Lunch
1.30 p.m.
Serological profiling of HBsAg mutants
Paul Coleman, Abbott Diagnostics, Abbott Park, IL
2.00 p.m.
Q & A
2.10 p.m.
Infectivity of S-gene HBV mutants in vaccinated chimpanzees
Saleem Kamili, CDC
2.40 p.m.
Q & A
Session V: Roundtable
(Moderator: John Ward, CDC)
2.50 p.m.
Future directions in anti-HBV therapeutics
Tim Block, Drexel University & Hepatitis B Foundation, Doylestown, PA
3.05 p.m.
Implications for clinical management
Adrian Di Bisceglie, St Louis University, St Louis, MN
3.20 p.m.
Forging laboratory tools for surveillance
Chong-Gee Teo, CDC
3.35 p.m.
Implications for vaccination
Trudy Murphy, CDC
3.50 p.m.
Discussion
4:15 p.m.
Adjourn
      

 
Contact Us
About Us

Web Link Legend:

Link external to CDC.  See Policies link in page footer. Outside CDC (disclaimer)

Link external to CDC.  See Policies link in page footer. Other Federal sites

Link external to CDC.  See Policies link in page footer. State/Local sites


USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #